BlackRock Japan’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

BlackRock Japan’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12K	Sell	362 -71	-16%	-$3.03K	﹤0.01%	1200
2016 Q3	$22K	Buy	433 +374	+634%	+$15.5K	﹤0.01%	1111
2016 Q2	$2K	Hold	59	–	–	﹤0.01%	1402
2016 Q1	$4K	Sell	59 -106	-64%	-$5.53K	﹤0.01%	1387
2015 Q4	$10K	Sell	165 -206	-56%	-$14.5K	﹤0.01%	1269
2015 Q3	$25K	Buy	371 +295	+388%	+$24.1K	﹤0.01%	1072
2015 Q2	$7K	Sell	76 -430	-85%	-$40.9K	﹤0.01%	1296
2015 Q1	$47K	Sell	506 -260	-34%	-$22.1K	﹤0.01%	1076
2014 Q4	$68K	Buy	766 +621	+428%	+$45.2K	﹤0.01%	1047
2014 Q3	$10K	Buy	+145	New	+$7.75K	﹤0.01%	1206

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's MACK Position: Q4 2016 in Review

BlackRock Japan reduced its Merrimack Pharmaceuticals, Inc. (MACK) stake by 16% in Q4 2016, selling an estimated $3.03K and leaving 362 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

BlackRock Japan first reported a position in MACK in Q3 2014 and has held it in 10 quarters since. The position peaked at $68K in Q4 2014. 136 funds tracked by Wall St. Rank hold MACK as of Q4 2016.

BlackRock Japan held 362 shares of Merrimack Pharmaceuticals, Inc. worth $12K as of Q4 2016.
BlackRock Japan sold 71 Merrimack Pharmaceuticals, Inc. shares in Q4 2016, an estimated $3.03K.
Merrimack Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1200 holding.
BlackRock Japan first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2014 and has held it in 10 quarters since.
BlackRock Japan's Merrimack Pharmaceuticals, Inc. position peaked at $68K in Q4 2014.
136 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.